awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27302763-7295D0A1-EB89-4F8E-B9A4-FE36D4705E78
Q27302763-7295D0A1-EB89-4F8E-B9A4-FE36D4705E78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302763-7295D0A1-EB89-4F8E-B9A4-FE36D4705E78
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An
P577
Q27302763-7295D0A1-EB89-4F8E-B9A4-FE36D4705E78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302763-7295D0A1-EB89-4F8E-B9A4-FE36D4705E78
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3095bafa983f2d48ab93eaaac948028ad3804ca
P577
2015-03-24T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
661d32d39afe5af0e8bacfa328307a83